Literature DB >> 11874981

Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction.

William E Smoyer1, Richard F Ransom.   

Abstract

Nephrotic syndrome (NS) is characterized by structural changes in the actin-rich foot processes of glomerular podocytes. We previously identified high concentrations of the small heat shock protein hsp27 within podocytes as well as increased glomerular accumulation and phosphorylation of hsp27 in puromycin aminonucleoside (PAN) -induced experimental NS. Here we analyzed murine podocytes stably transfected with hsp27 sense, antisense, and vector control constructs using a newly developed in vitro PAN model system. Cell morphology and the microfilament structure of untreated sense and antisense transfectants were altered compared with controls. Vector cell survival, polymerized actin content, cell area, and hsp27 content increased after 1.25 microg/ml PAN treatment and decreased after 5.0 microg/ml treatment. In contrast, sense cells were unaffected by 1.25 microg/ml PAN treatment whereas antisense cells showed decreases or no changes in all parameters. Treatment of sense cells with 5.0 microg/ml PAN resulted in increased cell survival and cell area whereas antisense cells underwent significant decreases in all parameters. Hsp27 provided dramatic protection against PAN-induced microfilament disruption in sense > vector > antisense cells. We conclude that hsp27 is able to regulate both the morphological and actin cytoskeletal response of podocytes in an in vitro model of podocyte injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874981     DOI: 10.1096/fj.01-0681com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

1.  Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.

Authors:  Seetharamaiah Chittiprol; Phylip Chen; Danica Petrovic-Djergovic; Tad Eichler; Richard F Ransom
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

2.  Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.

Authors:  Shipra Agrawal; Adam J Guess; Rainer Benndorf; William E Smoyer
Journal:  Mol Pharmacol       Date:  2011-06-02       Impact factor: 4.436

Review 3.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

4.  A new locus for familial FSGS on chromosome 2p.

Authors:  Rasheed Gbadegesin; Peter Lavin; Louis Janssens; Bartlomiej Bartkowiak; Alison Homstad; Guanghong Wu; Brandy Bowling; Jason Eckel; Chris Potocky; Diana Abbott; Peter Conlon; William K Scott; David Howell; Elizabeth Hauser; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

5.  Ammonium affects tight junctions and the cytoskeleton in MDCK cells.

Authors:  M Vastag; W Neuhofer; W Nagel; F X Beck
Journal:  Pflugers Arch       Date:  2004-09-08       Impact factor: 3.657

Review 6.  Heat shock proteins and kidney disease: perspectives of HSP therapy.

Authors:  Natalia Chebotareva; Irina Bobkova; Evgeniy Shilov
Journal:  Cell Stress Chaperones       Date:  2017-04-13       Impact factor: 3.667

Review 7.  Heat shock proteins in the kidney.

Authors:  Rajasree Sreedharan; Scott K Van Why
Journal:  Pediatr Nephrol       Date:  2016-02-25       Impact factor: 3.714

8.  Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.

Authors:  Rudolf Fuchshofer; Sabrina Ullmann; Ludwig F Zeilbeck; Matti Baumann; Benjamin Junglas; Ernst R Tamm
Journal:  Histochem Cell Biol       Date:  2011-08-04       Impact factor: 4.304

Review 9.  Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.

Authors:  Mirco Belingheri; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-03       Impact factor: 3.902

10.  Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC.

Authors:  Jun Ma; Lynetta Phillips; Ying Wang; Tiane Dai; Janine LaPage; Rama Natarajan; Sharon G Adler
Journal:  BMC Complement Altern Med       Date:  2010-11-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.